カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Oral Levothyroxine Sodium Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19486）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19486
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

経口用レボチロキシンナトリウム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経口用レボチロキシンナトリウムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経口用レボチロキシンナトリウム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・25mcg、50mcg、75mcg、その他

用途別セグメントは次のように区分されます。
・薬局、病院、その他

世界の経口用レボチロキシンナトリウム市場の主要な市場プレーヤーは以下のとおりです。
・Abbvie、Mylan Pharma、Merck、Pfizer、Lannett Company、Novartis、IBSA、Piramal Critical Care、Abbott

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経口用レボチロキシンナトリウム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口用レボチロキシンナトリウムメーカーの企業概要、2019年～2022年までの経口用レボチロキシンナトリウムの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口用レボチロキシンナトリウムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経口用レボチロキシンナトリウムの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経口用レボチロキシンナトリウムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経口用レボチロキシンナトリウム市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経口用レボチロキシンナトリウムの産業チェーンを掲載しています。
・第13、14、15章では、経口用レボチロキシンナトリウムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 経口用レボチロキシンナトリウムの概要
- 種類別分析（2017年vs2021年vs2028年）：25mcg、50mcg、75mcg、その他
- 用途別分析（2017年vs2021年vs2028年）：薬局、病院、その他
- 世界の経口用レボチロキシンナトリウム市場規模・予測
- 世界の経口用レボチロキシンナトリウム生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Abbvie、Mylan Pharma、Merck、Pfizer、Lannett Company、Novartis、IBSA、Piramal Critical Care、Abbott
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：25mcg、50mcg、75mcg、その他
・用途別分析2017年-2028年：薬局、病院、その他
・経口用レボチロキシンナトリウムの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経口用レボチロキシンナトリウムのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経口用レボチロキシンナトリウムのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経口用レボチロキシンナトリウムの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・経口用レボチロキシンナトリウムの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oral Levothyroxine Sodium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Levothyroxine Sodium market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Pharmacy accounting for % of the Oral Levothyroxine Sodium global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 25 mcg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Levothyroxine Sodium include Abbvie, Mylan Pharma, Merck, Pfizer, and Lannett Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Levothyroxine Sodium market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
25 mcg
50 mcg
75 mcg
Others
Market segment by Application can be divided into
Pharmacy
Hospital
Others
The key market players for global Oral Levothyroxine Sodium market are listed below:
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
IBSA
Piramal Critical Care
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Levothyroxine Sodium product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Levothyroxine Sodium, with price, sales, revenue and global market share of Oral Levothyroxine Sodium from 2019 to 2022.
Chapter 3, the Oral Levothyroxine Sodium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Levothyroxine Sodium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Levothyroxine Sodium market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Levothyroxine Sodium.
Chapter 13, 14, and 15, to describe Oral Levothyroxine Sodium sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Oral Levothyroxine Sodium Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Levothyroxine Sodium Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 25 mcg
1.2.3 50 mcg
1.2.4 75 mcg
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Levothyroxine Sodium Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Others
1.4 Global Oral Levothyroxine Sodium Market Size & Forecast
1.4.1 Global Oral Levothyroxine Sodium Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Levothyroxine Sodium Sales in Volume (2017-2028)
1.4.3 Global Oral Levothyroxine Sodium Price (2017-2028)
1.5 Global Oral Levothyroxine Sodium Production Capacity Analysis
1.5.1 Global Oral Levothyroxine Sodium Total Production Capacity (2017-2028)
1.5.2 Global Oral Levothyroxine Sodium Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Levothyroxine Sodium Market Drivers
1.6.2 Oral Levothyroxine Sodium Market Restraints
1.6.3 Oral Levothyroxine Sodium Trends Analysis
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Oral Levothyroxine Sodium Product and Services
2.1.4 Abbvie Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Mylan Pharma
2.2.1 Mylan Pharma Details
2.2.2 Mylan Pharma Major Business
2.2.3 Mylan Pharma Oral Levothyroxine Sodium Product and Services
2.2.4 Mylan Pharma Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Oral Levothyroxine Sodium Product and Services
2.3.4 Merck Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Oral Levothyroxine Sodium Product and Services
2.4.4 Pfizer Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lannett Company
2.5.1 Lannett Company Details
2.5.2 Lannett Company Major Business
2.5.3 Lannett Company Oral Levothyroxine Sodium Product and Services
2.5.4 Lannett Company Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Oral Levothyroxine Sodium Product and Services
2.6.4 Novartis Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 IBSA
2.7.1 IBSA Details
2.7.2 IBSA Major Business
2.7.3 IBSA Oral Levothyroxine Sodium Product and Services
2.7.4 IBSA Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Piramal Critical Care
2.8.1 Piramal Critical Care Details
2.8.2 Piramal Critical Care Major Business
2.8.3 Piramal Critical Care Oral Levothyroxine Sodium Product and Services
2.8.4 Piramal Critical Care Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Oral Levothyroxine Sodium Product and Services
2.9.4 Abbott Oral Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Levothyroxine Sodium Breakdown Data by Manufacturer
3.1 Global Oral Levothyroxine Sodium Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Levothyroxine Sodium Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Levothyroxine Sodium
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Levothyroxine Sodium Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Levothyroxine Sodium Manufacturer Market Share in 2021
3.5 Global Oral Levothyroxine Sodium Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Levothyroxine Sodium Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Levothyroxine Sodium Market Size by Region
4.1.1 Global Oral Levothyroxine Sodium Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Levothyroxine Sodium Revenue by Region (2017-2028)
4.2 North America Oral Levothyroxine Sodium Revenue (2017-2028)
4.3 Europe Oral Levothyroxine Sodium Revenue (2017-2028)
4.4 Asia-Pacific Oral Levothyroxine Sodium Revenue (2017-2028)
4.5 South America Oral Levothyroxine Sodium Revenue (2017-2028)
4.6 Middle East and Africa Oral Levothyroxine Sodium Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Levothyroxine Sodium Sales in Volume by Type (2017-2028)
5.2 Global Oral Levothyroxine Sodium Revenue by Type (2017-2028)
5.3 Global Oral Levothyroxine Sodium Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Levothyroxine Sodium Sales in Volume by Application (2017-2028)
6.2 Global Oral Levothyroxine Sodium Revenue by Application (2017-2028)
6.3 Global Oral Levothyroxine Sodium Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Levothyroxine Sodium Sales by Type (2017-2028)
7.2 North America Oral Levothyroxine Sodium Sales by Application (2017-2028)
7.3 North America Oral Levothyroxine Sodium Market Size by Country
7.3.1 North America Oral Levothyroxine Sodium Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Levothyroxine Sodium Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Levothyroxine Sodium Sales by Type (2017-2028)
8.2 Europe Oral Levothyroxine Sodium Sales by Application (2017-2028)
8.3 Europe Oral Levothyroxine Sodium Market Size by Country
8.3.1 Europe Oral Levothyroxine Sodium Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Levothyroxine Sodium Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Levothyroxine Sodium Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Levothyroxine Sodium Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Levothyroxine Sodium Market Size by Region
9.3.1 Asia-Pacific Oral Levothyroxine Sodium Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Levothyroxine Sodium Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Levothyroxine Sodium Sales by Type (2017-2028)
10.2 South America Oral Levothyroxine Sodium Sales by Application (2017-2028)
10.3 South America Oral Levothyroxine Sodium Market Size by Country
10.3.1 South America Oral Levothyroxine Sodium Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Levothyroxine Sodium Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Levothyroxine Sodium Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Levothyroxine Sodium Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Levothyroxine Sodium Market Size by Country
11.3.1 Middle East & Africa Oral Levothyroxine Sodium Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Levothyroxine Sodium Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Levothyroxine Sodium and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Levothyroxine Sodium
12.3 Oral Levothyroxine Sodium Production Process
12.4 Oral Levothyroxine Sodium Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Levothyroxine Sodium Typical Distributors
13.3 Oral Levothyroxine Sodium Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Oral Levothyroxine Sodium Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Levothyroxine Sodium Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbvie Basic Information, Manufacturing Base and Competitors
Table 4. Abbvie Major Business
Table 5. Abbvie Oral Levothyroxine Sodium Product and Services
Table 6. Abbvie Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Mylan Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Pharma Major Business
Table 9. Mylan Pharma Oral Levothyroxine Sodium Product and Services
Table 10. Mylan Pharma Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Oral Levothyroxine Sodium Product and Services
Table 14. Merck Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Oral Levothyroxine Sodium Product and Services
Table 18. Pfizer Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 20. Lannett Company Major Business
Table 21. Lannett Company Oral Levothyroxine Sodium Product and Services
Table 22. Lannett Company Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Oral Levothyroxine Sodium Product and Services
Table 26. Novartis Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. IBSA Basic Information, Manufacturing Base and Competitors
Table 28. IBSA Major Business
Table 29. IBSA Oral Levothyroxine Sodium Product and Services
Table 30. IBSA Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Piramal Critical Care Basic Information, Manufacturing Base and Competitors
Table 32. Piramal Critical Care Major Business
Table 33. Piramal Critical Care Oral Levothyroxine Sodium Product and Services
Table 34. Piramal Critical Care Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Abbott Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Oral Levothyroxine Sodium Product and Services
Table 38. Abbott Oral Levothyroxine Sodium Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Oral Levothyroxine Sodium Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Oral Levothyroxine Sodium Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Oral Levothyroxine Sodium, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Oral Levothyroxine Sodium Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Oral Levothyroxine Sodium Production Site of Key Manufacturer
Table 44. Oral Levothyroxine Sodium New Entrant and Capacity Expansion Plans
Table 45. Oral Levothyroxine Sodium Mergers & Acquisitions in the Past Five Years
Table 46. Global Oral Levothyroxine Sodium Sales by Region (2017-2022) & (K Units)
Table 47. Global Oral Levothyroxine Sodium Sales by Region (2023-2028) & (K Units)
Table 48. Global Oral Levothyroxine Sodium Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Oral Levothyroxine Sodium Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Oral Levothyroxine Sodium Sales by Type (2017-2022) & (K Units)
Table 51. Global Oral Levothyroxine Sodium Sales by Type (2023-2028) & (K Units)
Table 52. Global Oral Levothyroxine Sodium Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Oral Levothyroxine Sodium Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Oral Levothyroxine Sodium Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Oral Levothyroxine Sodium Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Oral Levothyroxine Sodium Sales by Application (2017-2022) & (K Units)
Table 57. Global Oral Levothyroxine Sodium Sales by Application (2023-2028) & (K Units)
Table 58. Global Oral Levothyroxine Sodium Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Oral Levothyroxine Sodium Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Oral Levothyroxine Sodium Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Oral Levothyroxine Sodium Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Oral Levothyroxine Sodium Sales by Country (2017-2022) & (K Units)
Table 63. North America Oral Levothyroxine Sodium Sales by Country (2023-2028) & (K Units)
Table 64. North America Oral Levothyroxine Sodium Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Oral Levothyroxine Sodium Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Oral Levothyroxine Sodium Sales by Type (2017-2022) & (K Units)
Table 67. North America Oral Levothyroxine Sodium Sales by Type (2023-2028) & (K Units)
Table 68. North America Oral Levothyroxine Sodium Sales by Application (2017-2022) & (K Units)
Table 69. North America Oral Levothyroxine Sodium Sales by Application (2023-2028) & (K Units)
Table 70. Europe Oral Levothyroxine Sodium Sales by Country (2017-2022) & (K Units)
Table 71. Europe Oral Levothyroxine Sodium Sales by Country (2023-2028) & (K Units)
Table 72. Europe Oral Levothyroxine Sodium Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Oral Levothyroxine Sodium Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Oral Levothyroxine Sodium Sales by Type (2017-2022) & (K Units)
Table 75. Europe Oral Levothyroxine Sodium Sales by Type (2023-2028) & (K Units)
Table 76. Europe Oral Levothyroxine Sodium Sales by Application (2017-2022) & (K Units)
Table 77. Europe Oral Levothyroxine Sodium Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Oral Levothyroxine Sodium Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Oral Levothyroxine Sodium Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Oral Levothyroxine Sodium Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Oral Levothyroxine Sodium Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Oral Levothyroxine Sodium Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Oral Levothyroxine Sodium Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Oral Levothyroxine Sodium Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Oral Levothyroxine Sodium Sales by Application (2023-2028) & (K Units)
Table 86. South America Oral Levothyroxine Sodium Sales by Country (2017-2022) & (K Units)
Table 87. South America Oral Levothyroxine Sodium Sales by Country (2023-2028) & (K Units)
Table 88. South America Oral Levothyroxine Sodium Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Oral Levothyroxine Sodium Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Oral Levothyroxine Sodium Sales by Type (2017-2022) & (K Units)
Table 91. South America Oral Levothyroxine Sodium Sales by Type (2023-2028) & (K Units)
Table 92. South America Oral Levothyroxine Sodium Sales by Application (2017-2022) & (K Units)
Table 93. South America Oral Levothyroxine Sodium Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Oral Levothyroxine Sodium Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Oral Levothyroxine Sodium Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Oral Levothyroxine Sodium Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Oral Levothyroxine Sodium Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Oral Levothyroxine Sodium Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Oral Levothyroxine Sodium Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Oral Levothyroxine Sodium Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Oral Levothyroxine Sodium Sales by Application (2023-2028) & (K Units)
Table 102. Oral Levothyroxine Sodium Raw Material
Table 103. Key Manufacturers of Oral Levothyroxine Sodium Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Oral Levothyroxine Sodium Typical Distributors
Table 107. Oral Levothyroxine Sodium Typical Customers
List of Figures
Figure 1. Oral Levothyroxine Sodium Picture
Figure 2. Global Oral Levothyroxine Sodium Revenue Market Share by Type in 2021
Figure 3. 25 mcg
Figure 4. 50 mcg
Figure 5. 75 mcg
Figure 6. Others
Figure 7. Global Oral Levothyroxine Sodium Revenue Market Share by Application in 2021
Figure 8. Pharmacy
Figure 9. Hospital
Figure 10. Others
Figure 11. Global Oral Levothyroxine Sodium Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Oral Levothyroxine Sodium Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Oral Levothyroxine Sodium Sales (2017-2028) & (K Units)
Figure 14. Global Oral Levothyroxine Sodium Price (2017-2028) & (US$/Unit)
Figure 15. Global Oral Levothyroxine Sodium Production Capacity (2017-2028) & (K Units)
Figure 16. Global Oral Levothyroxine Sodium Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Oral Levothyroxine Sodium Market Drivers
Figure 18. Oral Levothyroxine Sodium Market Restraints
Figure 19. Oral Levothyroxine Sodium Market Trends
Figure 20. Global Oral Levothyroxine Sodium Sales Market Share by Manufacturer in 2021
Figure 21. Global Oral Levothyroxine Sodium Revenue Market Share by Manufacturer in 2021
Figure 22. Oral Levothyroxine Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Oral Levothyroxine Sodium Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Oral Levothyroxine Sodium Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Oral Levothyroxine Sodium Sales Market Share by Region (2017-2028)
Figure 26. Global Oral Levothyroxine Sodium Revenue Market Share by Region (2017-2028)
Figure 27. North America Oral Levothyroxine Sodium Revenue (2017-2028) & (USD Million)
Figure 28. Europe Oral Levothyroxine Sodium Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Oral Levothyroxine Sodium Revenue (2017-2028) & (USD Million)
Figure 30. South America Oral Levothyroxine Sodium Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Oral Levothyroxine Sodium Revenue (2017-2028) & (USD Million)
Figure 32. Global Oral Levothyroxine Sodium Sales Market Share by Type (2017-2028)
Figure 33. Global Oral Levothyroxine Sodium Revenue Market Share by Type (2017-2028)
Figure 34. Global Oral Levothyroxine Sodium Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Oral Levothyroxine Sodium Sales Market Share by Application (2017-2028)
Figure 36. Global Oral Levothyroxine Sodium Revenue Market Share by Application (2017-2028)
Figure 37. Global Oral Levothyroxine Sodium Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Oral Levothyroxine Sodium Sales Market Share by Type (2017-2028)
Figure 39. North America Oral Levothyroxine Sodium Sales Market Share by Application (2017-2028)
Figure 40. North America Oral Levothyroxine Sodium Sales Market Share by Country (2017-2028)
Figure 41. North America Oral Levothyroxine Sodium Revenue Market Share by Country (2017-2028)
Figure 42. United States Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Oral Levothyroxine Sodium Sales Market Share by Type (2017-2028)
Figure 46. Europe Oral Levothyroxine Sodium Sales Market Share by Application (2017-2028)
Figure 47. Europe Oral Levothyroxine Sodium Sales Market Share by Country (2017-2028)
Figure 48. Europe Oral Levothyroxine Sodium Revenue Market Share by Country (2017-2028)
Figure 49. Germany Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Oral Levothyroxine Sodium Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oral Levothyroxine Sodium Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Oral Levothyroxine Sodium Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Oral Levothyroxine Sodium Revenue Market Share by Region (2017-2028)
Figure 58. China Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Oral Levothyroxine Sodium Sales Market Share by Type (2017-2028)
Figure 65. South America Oral Levothyroxine Sodium Sales Market Share by Application (2017-2028)
Figure 66. South America Oral Levothyroxine Sodium Sales Market Share by Country (2017-2028)
Figure 67. South America Oral Levothyroxine Sodium Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Oral Levothyroxine Sodium Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Oral Levothyroxine Sodium Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Oral Levothyroxine Sodium Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Oral Levothyroxine Sodium Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Oral Levothyroxine Sodium Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Oral Levothyroxine Sodium in 2021
Figure 79. Manufacturing Process Analysis of Oral Levothyroxine Sodium
Figure 80. Oral Levothyroxine Sodium Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の注射用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）
  • 世界のレボチロキシンナトリウム錠市場2022年：市場規模予測（～2028年）
  • 世界のメトトレキサート（MTX）内用液市場2022年：市場規模予測（～2028年）
  • 世界の経口用ジドロゲステロン市場2022年：市場規模予測（～2028年）
  • 世界のエポプロステノールナトリウムFDF市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19486 )"世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）" (英文：Global Oral Levothyroxine Sodium Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。